Technology News and Research

RSS

Whole genome sequencing may help identify disease risks

Using a small amount of blood or saliva, a technology called whole genome sequencing makes that possible - and more than half of parents said they'd not only be interested in the technology for themselves but for their children too, a new nationally-representative University of Michigan study shows.

10 Mar 2015

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

Advanced Cell Diagnostics, Inc. (ACD) announced today that Merrimack Pharmaceuticals, Inc. is using ACD's RNAscope technology to select patients for its Phase 2 clinical trial of its product candidate MM-121.

From Advanced Cell Diagnostics 9 Mar 2015

The Brain Prize awarded to four scientists for development of two-photon microscopy

The world's most valuable (€1m) neuroscience prize, The Brain Prize has been awarded, to four scientists, Winfried Denk and Arthur Konnerth (Germany), and Karel Svoboda and David Tank (USA), for the invention and development of two-photon microscopy, a transformative tool in brain research.

9 Mar 2015

OSTAR announces global launch of new patient-centered Vendor Neutral Gateway

OSTAR Healthcare Technology, a Washington State-based Telehealth Solutions company, announced the global launch of its G4 Device Gateway. This revolutionary HIPAA compliant Vendor Neutral Gateway (VNG) provides seamless remote device integration and monitoring for devices such as multi-vendor Glucometers, Vital Signs, Blood Pressure and Weight Scales.

9 Mar 2015

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

The industry term ‘blood gas testing’ has come to mean the accurate measurement and reporting of a wide menu of blood parameters, all on a single platform.

From Siemens Healthineers Point of Care Diagnostics 9 Mar 2015

Loyola's Genomics Facility uses next generation sequencing to study genetic make-up of organisms

Loyola University Chicago's Genomics Facility is using an advanced technology called next generation sequencing to assist a broad range of researchers studying the genetic make-up of organisms ranging from viruses to humans.

9 Mar 2015

Phico Therapeutics gets £2.25M Translation Award to develop SASPject PT4 antibiotic for E. coli, K. pneumoniae

Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a £2.25M Translation Award by the Wellcome Trust to develop its SASPject PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumoniae.

9 Mar 2015

Exposure to hormone-disrupting chemicals can cause fatty liver disease, promote obesity

Exposure to low doses of hormone-disrupting chemicals early in life can alter gene expression in the liver as well as liver function, increasing the susceptibility to obesity and other metabolic diseases in adulthood, a new study finds.

9 Mar 2015

New type of vaccine holds promise for prevention of genital herpes

Scientists at Albert Einstein College of Medicine of Yeshiva University have designed a new type of vaccine that could be the first-ever for preventing genital herpes--one of the most common sexually transmitted diseases, affecting some 500 million people worldwide.

9 Mar 2015

Investment in science and engineering can make UK a successful nation

The UK needs to increase its investment in science and engineering research if it is to continue to be a successful nation.

9 Mar 2015

TSO3's new STERIZONE VP4 Sterilizer to be showcased at AORN Surgical Conference & Expo 2015

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings, announced today that it will showcase its new STERIZONE VP4 Sterilizer at the AORN Surgical Conference & Expo 2015, held in Denver, Colorado from March 7 to 11, 2015.

6 Mar 2015

Oraya's IRay Radiotherapy system gets CE Mark to treat choroidal metastases

Oraya Therapeutics announced today that the Oraya IRay® Radiotherapy system has received a CE Mark extension for the treatment of choroidal metastases, a cancer in the eye, originating most commonly from primary sites in the breast or lung.

6 Mar 2015

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome.

6 Mar 2015

Psychedelics does not increase risk of mental health problems

The use of psychedelics, such as LSD and magic mushrooms, does not increase a person's risk of developing mental health problems, according to an analysis of information from more than 135,000 randomly chosen people, including 19,000 people who had used psychedelics.

5 Mar 2015

Bob Foster named recipient of HCP's 2015 Hospital IT Executive of the Year Award

Health Connect Partners, Inc., a healthcare education firm, announced today that Bob Foster is the recipient of the company's 2015 Hospital IT Executive of the Year Award.

5 Mar 2015

Medical Diagnostic Laboratories now offers new HPV tests

Medical Diagnostic Laboratories, L.L.C., a CLIA-certified, CAP-accredited laboratory which specializes in high complexity, state-of-the-art, automated DNA-based molecular analyses, announces that it is now offering new Human Papillomavirus (HPV) testing which utilizes cutting edge technology, including next- generation DNA sequencing platforms.

5 Mar 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

Mallinckrodt plc, a leading global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion.

5 Mar 2015

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has initiated a pilot study to assess the feasibility of VolitionRx's proprietary NuQ assays in detecting prostate cancer.

5 Mar 2015

Lucideon welcomes University College Dublin students on work placements

Lucideon is pleased to announce that it has offered three healthcare technology placements to students from University College Dublin (UCD).

From Lucideon 5 Mar 2015

Philips, UC Irvine partner to explore effectiveness of spectral imaging in breast density measurement

Royal Philips today announced its collaboration with the University of California, Irvine, to explore how spectral breast imaging can improve breast density measurement, potentially aiding clinicians in more accurately gauging breast cancer risks and monitoring changes over time.

5 Mar 2015

Technology News and Research

Whole genome sequencing may help identify disease risks

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

The Brain Prize awarded to four scientists for development of two-photon microscopy

OSTAR announces global launch of new patient-centered Vendor Neutral Gateway

Blood gas testing: an interview with David Stein, PhD, CEO, Point of Care, Siemens Healthcare Diagnostics

Loyola's Genomics Facility uses next generation sequencing to study genetic make-up of organisms

Phico Therapeutics gets £2.25M Translation Award to develop SASPject PT4 antibiotic for E. coli, K. pneumoniae

Exposure to hormone-disrupting chemicals can cause fatty liver disease, promote obesity

New type of vaccine holds promise for prevention of genital herpes

Investment in science and engineering can make UK a successful nation

TSO3's new STERIZONE VP4 Sterilizer to be showcased at AORN Surgical Conference & Expo 2015

Oraya's IRay Radiotherapy system gets CE Mark to treat choroidal metastases

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

Psychedelics does not increase risk of mental health problems

Bob Foster named recipient of HCP's 2015 Hospital IT Executive of the Year Award

Medical Diagnostic Laboratories now offers new HPV tests

Mallinckrodt enters into definitive agreement to acquire Ikaria

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

Lucideon welcomes University College Dublin students on work placements

Philips, UC Irvine partner to explore effectiveness of spectral imaging in breast density measurement

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News